Stratify 10-yr ASCVD risk via PCE and/or PREVENT, then use risk enhancers and CAC to refine shared-decision statin prescription. Treat borderline+ with lifestyle + statin by intensity tier; address BP, diabetes, and lipoprotein(a) in parallel.
Authored pathway active · cardio.ascvd.primary_prevention.outpatient
Stratify 10-yr ASCVD risk via PCE and/or PREVENT, then use risk enhancers and CAC to refine shared-decision statin prescription. Treat borderline+ with lifestyle + statin by intensity tier; address BP, diabetes, and lipoprotein(a) in parallel.
Guidelines: ACC/AHA 2018 Cholesterol Guideline · ACC/AHA 2019 Primary Prevention of Cardiovascular Disease · ACC/AHA 2025 Hypertension Update
Phenotypes (11)
- Low 10-yr ASCVD risk (< 5%)
- Borderline 10-yr ASCVD risk (5–7.4%)
- Intermediate 10-yr ASCVD risk (7.5–19.9%)
- High 10-yr ASCVD risk (≥ 20%)
- +7 more
Red flags (6)
- New chest pain, pressure, or anginal equivalent → ACS workup requiredCRITICAL
- New focal neurologic deficit or TIA symptomsCRITICAL
- Syncope or near-syncope with exertionHIGH
- Severe hypertension (≥ 180/120) with end-organ symptomsHIGH
- +2 more
Pathway-scoped symptom and exam intake
Test this pathway's ROS and differential links
Uses LR engine cardio.ascvd.chronic.v1, then routes suggested engines into the workspace.
19-panel workspace
cardio.ascvd.primary_prevention · OutpatientStart patient workup
Open a scratch or linked encounter, add active problems, then keep labs, fluids, acid-base, and electrolyte tools beside the main workspace instead of losing context.
Encounter and problems
No encounter open. Add a problem to create a scratch encounter when none is open.
Multi-window tools
Unified
labs + fluids + acid-base
Labs
fast lab analyzer
Fluid
resuscitation and balance
Electrolytes
Na/K/Mg/Phos/Ca
ABG/VBG
compensation and mixed disorders
Popular entry points
6 quick-startsOr jump straight to the atlas
The Engine Atlas covers every authored disease package with setting chips and pathway badges. Open any engine to load its 19-panel workspace, backed by phenotype-aware reasoning and monitored by the Flow Assistant.